Anzeige
Mehr »
Login
Samstag, 25.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Achtung! Ist das die Krypto-Aktie des Jahres 2024 mit 700% Potential?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3D506 | ISIN: US8342235053 | Ticker-Symbol: DOA
NASDAQ
24.05.24
22:00 Uhr
0,365 US-Dollar
+0,006
+1,67 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
SOLIGENIX INC Chart 1 Jahr
5-Tage-Chart
SOLIGENIX INC 5-Tage-Chart

Aktuelle News zur SOLIGENIX Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoSoligenix Encourages Stockholders to Vote "FOR" Reverse Stock Split32Most shareholders can vote by calling 1-833-782-7145 PRINCETON, N.J., May 23, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company...
► Artikel lesen
17.05.SOLIGENIX, INC. - 8-K, Current Report2
16.05.SOLIGENIX, INC.: Positive Clinical Results from HyBryte Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice60Published Results Confirm and Extend Response Results from Phase 3 FLASH Study PRINCETON, N.J., May 16, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage...
► Artikel lesen
13.05.Soligenix Inc reports results for the quarter ended in January - Earnings Summary2
10.05.SOLIGENIX, INC. - 10-Q, Quarterly Report1
10.05.Soligenix GAAP EPS of -$0.18, revenue of $0.1M1
10.05.SOLIGENIX, INC.: Soligenix Announces Recent Accomplishments And First Quarter 2024 Financial Results189PRINCETON, N.J., May 10, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products...
► Artikel lesen
22.04.SOLIGENIX, INC. - 8-K, Current Report3
15.04.Soligenix bags orpan drug designation for Marburg virus vaccine2
15.04.Why Is Soligenix (SNGX) Stock Up 58% Today?4
15.04.Soligenix stock soars 106% on FDA orphan drug status4
15.04.SOLIGENIX, INC.: FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg Marburgvirus Infection1.158Provides MarVax Heat Stable Vaccine Seven Years of U.S. Market Exclusivity Upon FDA Approval PRINCETON, N.J., April 15, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company)...
► Artikel lesen
11.04.Soligenix Granted FDA Orphan Drug Designation for SuVax Active Ingredient3
11.04.Soligenix's SuVax Granted FDA Orphan Drug Designation For Prevention Of Sudan Ebolavirus Infection2
11.04.FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection452Provides SuVax Heat Stable Vaccine Seven Years of U.S. Market Exclusivity Upon FDA Approval PRINCETON, N.J., April 11, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company)...
► Artikel lesen
03.04.SOLIGENIX, INC. - 8-K, Current Report3
02.04.SOLIGENIX, INC. - S-1/A, General form for registration of securities1
15.03.SOLIGENIX, INC. - S-1/A, General form for registration of securities2
15.03.SOLIGENIX, INC. - 10-K, Annual Report3
15.03.Recap: Soligenix Q4 Earnings1
Seite:  Weiter >>
47 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1